Lowest Price Guaranteed From USD 4,799
Published
October 2022
Pages
345
View Count
33443
Example Insights
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Report Description
Due to several factors, such as steady rise in global clinical trials, demand for highly specific study participants, and complex inclusion-exclusion criteria, and the challenges associated with enrolling patients in modern clinical trials, pharmaceutical companies are increasingly using the services of dedicated patient recruitment firms.
-- Chief Operations Officer, Israel-based Small-sized Patient Recruitment Firm
The global clinical trial patient recruitment services market was valued at USD 9.4 billion in 2022; it is estimated to grow at compounded annual growth rate (CAGR) of 8.2% during the forecast period. Clinical trials form an integral part of the overall drug development process, enabling the necessary evaluation of the safety and efficacy of a drug candidate. As these trials are prone to delays, and can even fail altogether, they impose an immense financial pressure on sponsors. Studies suggest that around 40% of the total investment made for the development of a drug candidate is dedicated to clinical trials. However, the conduct of such trials is often fraught with challenges, including scientific and operational complexity, concerns associated with recruitment and retention of suitable patients, issues related to data handling and increasingly stringent regulatory guidelines. Further, owing to the inherent complexity of the overall process and involvement of several different stakeholders, these trials are prone to delays. It is worth mentioning that around 80% of the clinical trials are delayed due to insufficient patient recruitment. Further, retaining patients is also a major concern in pharmaceutical research and development; 15% to 40% of the enrolled patients drop out before the studies are completed, significantly impacting product approvals / launch timelines. Therefore, patient outreach, recruitment and retention strategies have evolved significantly, especially with the availability of a variety of digital data generation, management and marketing solutions. In fact, a number of modern technology-enabled offerings are now available to support various aspects of clinical research and patient recruitment.
The Clinical Trial Patient Recruitment Services Market (3rd Edition), 2022-2035: Distribution by Therapeutic Area (Cardiovascular Diseases, Oncological Disorders, Infectious Diseases, CNS Disorders, Respiratory Disorders, Hematological Disorders, Dermatological Disorders, Ophthalmic Disorders and Others), Patient Recruitment Step (Pre-screening and Screening), Trial Phase (Phase I, Phase II, Phase III and Phase IV) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa and Rest of the World report features an extensive study of the current market size and future market growth of the clinical trial recruitment market, over the forecast period. The research report also features an in-depth analysis, highlighting the capabilities of various clinical trial recruitment companies engaged in this field. Amongst other elements, the market report analyzes the patient recruitment market from the perspective of drug developers, patient recruitment organizations and investors.
Amongst several known challenges, patient recruitment is considered to be one of the rate limiting steps when it comes to getting drugs to the market. Presently, more than 155 companies have the required capabilities to offer patient recruitment and retention services across different geographical locations. Such clinical trial recruitment companies employ a variety of outreach methods and, over time, have attained a vital role in the successful conduct of clinical research. Further, several contract service providers are entering into strategic alliances in order to enhance their respective capabilities and offer an expanded portfolio of services to their clients. One such example is the collaboration of Trialbee and Worldwide Clinical Trials. The two companies announced their partnership in May 2021, which was aimed at faster patient recruitment and bringing down the cost of drug development for their clients.
The patient recruitment companies are also continuously expanding their portfolio. In addition to the patient enrollment service that targets biopharmaceutical industry, some companies also offer clinical trial matching services. Such services are targeted towards the patients and / or their physicians, allowing the aware and interested patients to find the right clinical trials for which they are eligible. Some clinical trial recruitment companies like Antidote and Foundation Medicine offer clinical trial matching services.
The patient recruitment services market is anticipated to grow at a CAGR of 8.2% over the forecast period of this market report. Owing to the need for large and diverse patient populations, phase III trials are anticipated to be responsible for the maximum share of revenues within this industry. Currently, in terms of therapeutic area, the market is captured by patient recruitment projects for trials evaluating drugs intended for the treatment of cardiovascular disorders. However, this trend is likely to change in the foreseen future with the rising clinical trials focusing on therapeutics targeting oncological disorders. Specifically, in terms of geography, the patient recruitment services market in Asia Pacific is likely to grow at a relatively faster pace during the forecast period.
Several small and mid-sized players do not have dedicated patient enrolment teams and lack the necessary capabilities / expertise to successfully recruit desired number of patients in clinical trials. In some cases, the clinical studies are too large or geographically broad to be managed by internal staff. Further, the stringent ethical and regulatory guidelines associated with patient enrollment in trials impose a significant burden on drug developers. As a result, outsourcing has become a popular operating model with regards to patient recruitment and patient retention; several specialty clinical trial recruitment companies, with expertise and experience in this domain, are driving the market growth of this upcoming segment of the healthcare market. The advantages of engaging contract service providers are numerous and enable sponsors to meet their clinical research timelines and thereby, launch respective offerings as planned.
Over the past decade, the patient recruitment industry has witnessed tremendous increase in the use of social media platforms, including Facebook, Instagram, Pinterest, LinkedIn and Twitter, and mobile applications for engaging and recruiting patients in clinical studies; these approaches are cost-effective and can be used to connect with diverse and hard-to-reach patient populations. In pursuit of capability and competence improvements, several service providers have also begun adopting and implementing modern technical strategies, such as Electronic Health Records (EHRs) and Real-World Evidence (RWE) for patient enrolment; these novel methods tend to be more efficient and yield a narrow pool of potentially eligible participants for targeted mailings. As patient recruitment companies evaluate novel technologies to improve the success rate of patient enrolment and more drug developers outsource the recruitment operations, the global market size for patient recruitment services will continue to witness growth during the forecast period.
The primary challenge faced by patient recruitment and retention service providers is the lack of awareness amongst individuals regarding the clinical studies and the benefits offered to study participants. Further, pharmaceutical companies do not allocate adequate budget for carrying out the patient enrolment process. Specifically for clinical trials evaluating orphan drugs and personalized therapies, finding the specialized pool of eligible patients is a burdensome and costly task. During our research we came across more than 55 clinical trial recruitment companies who are offering services for rare diseases / personalized therapies.
Other challenges in this domain include fear of individuals about the adverse events associated with clinical trials, lack of communication between study participants and researchers due to language barrier, and large geographical distance between the patient’s residence and study site, which affect the participation and retention of patients in research studies.
Owing to rise in the number of clinical trials that seek to enroll millions of patients, and complexities associated with patient accrual, drug developers are likely to outsource the patient recruitment and retention process to service providers. The number of clinical trials registered on clinicaltrials.gov has increased exponentially from around 2,000 studies in the year 2000 to more than 400,000 trials in 2022 (as of July 31). The increase in the number of trials justifies the rise in the number of trial participants to be enrolled, which became prominent during the COVID-19 vaccine trials as they were large multi-centre and multi-country trials.
Moreover, we believe that increase in clinical development activity in emerging markets, availability of one-stop patient recruitment service providers, and stringent regulations related to patient enrollment are likely to provide further impetus to the market size for patient recruitment services.
Several recent developments have taken place in the field of patient recruitment and patient retention. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
Global Clinical Trial Patient Recruitment Services: Market Segmentations
Report Attribute | Details | |
Forecast Period |
2022 – 2035 |
|
Base Year | 2022 | |
Market Size 2022 | $9.4 billion | |
CAGR | 8.2% | |
Patient Recruitment Step |
Pre-screening, Screening |
|
Trial Phase |
Phase 1, Phase 2, Phase 3, Phase 4 | |
Therapeutic Area |
Cardiovascular Diseases, Oncological Disorders, Infectious Diseases, CNS Disorders, Respiratory Disorders, Hematological Disorders, Dermatological Disorders, Ophthalmic Disorders, Others | |
Key Geographies |
North America, Europe, Asia-Pacific, MENA, Latin America, Rest of the World |
The market research report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:
One of the key objectives of the market report was to evaluate the current opportunity and the future growth potential of the patient recruitment services market over the forecast period. We have provided an informed estimate on the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. The report also features a likely distribution of the current and forecasted opportunity across important parameters, such as [A] patient recruitment steps (pre-screening and screening), [B] trial phase (phase I, phase II, phase III and phase IV), [C] therapeutic area (cardiovascular disorders, oncological disorders, infectious diseases, CNS disorders, respiratory disorders, haematological disorders, metabolic disorders, dermatological disorders, ophthalmic disorders and others) and [D] key geographies (North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America and Rest of the World).
In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
The opinions and insights presented in this market report were also influenced by discussions held with senior stakeholders in the industry. The research report features detailed transcripts of interviews held with the following individuals:
Contents
1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Clinical Trials
3.2.1 Clinical Trial Phases
3.3. Patient Recruitment in Clinical Trials
3.3.1. Patient Recruitment Process
3.3.2. Challenges Associated with Patient Recruitment
3.3.3. Strategies to Improve Patient Recruitment
3.3.4. Ethical Considerations
3.4. Outsourcing Patient Recruitment
3.4.1. Patient Recruitment-related Services
3.5. Patient Retention
3.5.1. Patient Retention-related Services
3.6. Concluding Remarks
4. PATIENT OUTREACH METHODS
4.1. Chapter Overview
4.2. Patient Outreach Methods
4.2.1. Traditional Patient Outreach Methods
4.2.1.1. Physician Referrals
4.2.1.2. Television
4.2.1.3. Radio
4.2.1.4. Print Media
4.2.1.5. Direct Mail Campaign
4.2.1.6. Cold Call / Call Centre
4.2.1.7. Advantages and Limitations of Traditional Media
4.2.2. Emerging Patient Outreach Methods
4.2.2.1. Social Media
4.2.2.1.1. Geo-Social Media
4.2.2.1.2. Social Networking Websites
4.2.2.1.3. Advantages and Limitations of Social Media
4.2.2.2. Mobile / Software Applications
4.2.2.3. Patient Networks
4.2.2.4. Patient Advocacy Groups
4.2.2.5. Electronic Medical Records (EMRs) / Electronic Health Records (EHRs) and Other Health Registries
4.2.2.6. Search Engine Marketing / Artificial Intelligence-based Marketing
4.2.2.7. Over-the-top (OTT) Media Platforms
4.2.2.8. Indication Specific Events for Patients
4.2.3. Best Practices / Recommendations for Patient Outreach
5. MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Patient Recruitment Companies: Overall Market Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Company Size and Location of Headquarters
5.2.5. Analysis by Patient Recruitment Services Offered
5.2.6. Analysis by Patient Outreach Methods
5.2.7. Analysis by Patient Recruitment Associated Service(s) Offered
5.2.8. Analysis by Patient Retention Method(s) Used
5.2.9. Analysis by Geographical Reach
5.2.10. Analysis by Therapeutic Expertise
5.2.11. Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status
6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Assumptions and Key Parameters
6.3. Methodology
6.4. Patient Recruitment Companies: Company Competitiveness Analysis
6.4.1. Competitiveness Analysis: Small Companies
6.4.2. Competitiveness Analysis: Mid-Sized Companies
6.4.3. Competitiveness Analysis: Large and Very Large Companies
7. COMPANY PROFILES: CLINICAL TRIAL RECRUITMENT COMPANIES IN NORTH AMERICA
7.1. Chapter Overview
7.2. BBK Worldwide (A Publicis Health Company)
7.2.1. Company Overview
7.2.2. Patient Recruitment and Retention Services Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Continuum Clinical
7.3.1. Company Overview
7.3.2. Patient Recruitment and Retention Services Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. IQVIA
7.4.1. Company Overview
7.4.2. Patient Recruitment and Retention Services Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. United BioSource (UBC)
7.5.1. Company Overview
7.5.2. Patient Recruitment and Retention Services Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. WCG ThreeWire
7.6.1. Company Overview
7.6.2. Patient Recruitment and Retention Services Portfolio
7.6.3. Recent Developments and Future Outlook
8. COMPANY PROFILES: CLINICAL TRIAL RECRUITMENT COMPANIES IN EUROPE
8.1. Chapter Overview
8.2. Clariness
8.2.1. Company Overview
8.2.2. Patient Recruitment and Retention Services Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. Ignite Data
8.3.1. Company Overview
8.3.2. Capsule Communications: Patient Recruitment and Retention Services Portfolio
8.3.3. Recent Developments and Future Outlook
8.4. Innovative Trials
8.4.1. Company Overview
8.4.2. Patient Recruitment and Retention Services Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. One Research
8.5.1. Company Overview
8.5.2. Patient Recruitment and Retention Services Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. Orphan Reach
8.6.1. Company Overview
8.6.2. Patient Recruitment and Retention Services Portfolio
8.6.3. Recent Developments and Future Outlook
9. COMPANY PROFILES: CLINICAL TRIAL PATIENT RECRUITMENT COMPANIES IN ASIA-PACIFIC AND REST OF THE WORLD
9.1. Chapter Overview
9.2. 3H Medi Solution
9.2.1. Company Overview
9.2.2. Patient Recruitment and Retention Services Portfolio
9.2.3. Recent Developments and Future Outlook
9.3. Buzzreach
9.3.1. Company Overview
9.3.2. Patient Recruitment and Retention Services Portfolio
9.3.3. Recent Developments and Future Outlook
9.4. Current Medical Information Center (CMIC)
9.4.1. Company Overview
9.4.2. Patient Recruitment and Retention Services Portfolio
9.4.3. Recent Developments and Future Outlook
9.5. nRollmed
9.5.1. Company Overview
9.5.2. Patient Recruitment and Retention Services Portfolio
9.5.3. Recent Developments and Future Outlook
9.6. Trialfacts
9.6.1. Company Overview
9.6.2. Patient Recruitment and Retention Services Portfolio
9.6.3. Recent Developments and Future Outlook
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Patient Recruitment Services: List of Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Analysis by Focus Area
10.3.5. Analysis by Year of Partnership and Focus Area
10.3.6. Analysis by Therapeutic Area
10.3.7. Analysis by Type of Partner
10.3.8. Most Active Players: Analysis by Number of Partnerships
10.3.9. Analysis by Geography
10.3.9.1. Intracontinental and Intercontinental Deals
10.3.9.2. International and Local Deals
11. RECENT TRENDS IN PATIENT RECRUITMENT AND RETENTION
11.1. Chapter Overview
11.1.1. Campaigning on Social Media to Accelerate Patient Recruitment in Clinical Trials
11.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention
11.1.3. Use of EHR Data to Improve Patient Recruitment Rates
11.1.4. Use of Other Real-World Data Sources to Overcome Patient Enrolment-related Challenges
11.1.5. Use of Artificial Intelligence to Improve Patient Selection
11.1.6. Increase in Adoption of the Virtual Trial Model During the COVID-19 Pandemic
11.1.7. Growing Focus on Conducting Clinical Research in Emerging Markets
12. FUTURE GROWTH OPPORTUNITIES IN PATIENT RECRUITMENT
12.1. Chapter Overview
12.2. Continuous Rise in the Number of Global Clinical Trials
12.3. Rise in Demand for Orphan Drugs and Personalized Medicine
12.4. Increase in Offshoring Clinical Development Activity to Emerging Regions
12.5. Availability of Service Providers Offering One-Stop-Solutions
12.6. Stringent Regulations and Complex Study Protocols Prompting More Outsourcing
12.7. Impact of the COVID-19 Pandemic on Clinical Research Activity
12.8. Technological Advances in Clinical Trial Conduct
13. CASE STUDY: REGULATORY LANDSCAPE OF PATIENT RECRUITMENT
13.1. Chapter Overview
13.2. Regulatory Framework of Patient Recruitment
13.3. Regulations Involved in Patient Recruitment
13.3.1. ICH-GCP Guidelines
13.3.2. Declaration of Helsinki
13.3.3. General Data Privacy Regulation (GDPR)
13.3.4. Health Insurance Portability and Accountability Act (HIPAA)
14. PATIENT RECRUITMENT IN TRIALS FOCUSED ON PERSONALIZED MEDICINES AND RARE DISEASES
14.1. Chapter Overview
14.2. Clinical Trials Focused on Personalized Medicines and Rare Diseases
14.2.1. Key Challenges
14.2.2. Specialized Patient Outreach Methods
14.2.3. Key Players
15. ANALYSIS OF DEMAND FOR CLINICAL TRIAL PARTICIPANTS
15.1. Chapter Overview
15.2. Scope and Methodology
15.3. Clinical Trial Analysis
15.3.1. Analysis by Trial Registration Year and Enrolled Patient Population
15.3.2. Analysis by Trial Phase
15.4. Global Demand for Clinical Trial Participants
15.4.1. Analysis by Enrolled Patient Population
15.4.2. Analysis by Trial Phase
15.4.3. Analysis by Therapeutic Area
15.4.4. Analysis by Enrolled Patient Population and Geography
16. MARKET SIZING AND OPPORTUNITY ANALYSIS
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. Global Clinical Trial Patient Recruitment Services: Market Size, 2022-2035
16.4. Clinical Trial Patient Recruitment Services Market: Analysis by Patient Recruitment Steps, 2022-2035
16.5. Clinical Trial Patient Recruitment Services Market: Analysis by Trial Phase, 2022-2035
16.6. Clinical Trial Patient Recruitment Services Market: Analysis by Therapeutic Area, 2022-2035
16.7. Clinical Trial Patient Recruitment Services Market: Analysis by Geography, 2022-2035
16.7.1. Clinical Trial Patient Recruitment Services: Market Attractiveness Analysis by Country, 2022-2035
16.7.2. Clinical Trial Patient Recruitment Services Market in North America, 2022-2035
16.7.2.1. Clinical Trial Patient Recruitment Services Market in the US: Analysis by Trial Phase, 2022-2035
16.7.2.2. Clinical Trial Patient Recruitment Services Market in the US: Analysis by Therapeutic Area, 2022-2035
16.7.2.3. Clinical Trial Patient Recruitment Services Market in Canada: Analysis by Trial Phase, 2022-2035
16.7.2.4. Clinical Trial Patient Recruitment Services Market in Canada: Analysis by Therapeutic Area, 2022-2035
16.7.3. Clinical Trial Patient Recruitment Services Market in Europe, 2022-2035
16.7.3.1. Clinical Trial Patient Recruitment Services Market in Germany: Analysis by Trial Phase, 2022-2035
16.7.3.2. Clinical Trial Patient Recruitment Services Market in Germany: Analysis by Therapeutic Area, 2022-2035
16.7.3.3. Clinical Trial Patient Recruitment Services Market in France: Analysis by Trial Phase, 2022-2035
16.7.3.4. Clinical Trial Patient Recruitment Services Market in France: Analysis by Therapeutic Area, 2022-2035
16.7.3.5. Clinical Trial Patient Recruitment Services Market in the UK: Analysis by Trial Phase, 2022-2035
16.7.3.6. Clinical Trial Patient Recruitment Services Market in the UK: Analysis by Therapeutic Area, 2022-2035
16.7.3.7. Clinical Trial Patient Recruitment Services Market in Italy: Analysis by Trial Phase, 2022-2035
16.7.3.8. Clinical Trial Patient Recruitment Services Market in Italy: Analysis by Therapeutic Area, 2022-2035
16.7.3.9. Clinical Trial Patient Recruitment Services Market in Spain: Analysis by Trial Phase, 2022-2035
16.7.3.10. Clinical Trial Patient Recruitment Services Market in Spain: Analysis by Therapeutic Area, 2022-2035
16.7.3.11. Clinical Trial Patient Recruitment Services Market in Rest of Europe: Analysis by Trial Phase, 2022-2035
16.7.3.12. Clinical Trial Patient Recruitment Services Market in Rest of Europe: Analysis by Therapeutic Area, 2022-2035
16.7.4. Clinical Trial Patient Recruitment Services Market in Asia-Pacific, 2022-2035
16.7.4.1. Clinical Trial Patient Recruitment Services Market in Japan: Analysis by Trial Phase, 2022-2035
16.7.4.2. Clinical Trial Patient Recruitment Services Market in Japan: Analysis by Therapeutic Area, 2022-2035
16.7.4.3. Clinical Trial Patient Recruitment Services Market in South Korea: Analysis by Trial Phase, 2022-2035
16.7.4.4. Clinical Trial Patient Recruitment Services Market in South Korea: Analysis by Therapeutic Area, 2022-2035
16.7.4.5. Clinical Trial Patient Recruitment Services Market in Australia: Analysis by Trial Phase, 2022-2035
16.7.4.6. Clinical Trial Patient Recruitment Services Market in Australia: Analysis by Therapeutic Area, 2022-2035
16.7.4.7. Clinical Trial Patient Recruitment Services Market in China: Analysis by Trial Phase, 2022-2035
16.7.4.8. Clinical Trial Patient Recruitment Services Market in China: Analysis by Therapeutic Area, 2022-2035
16.7.4.9. Clinical Trial Patient Recruitment Services Market in India: Analysis by Trial Phase, 2022-2035
16.7.4.10. Clinical Trial Patient Recruitment Services Market in India: Analysis by Therapeutic Area, 2022-2035
16.7.5 Clinical Trial Patient Recruitment Services Market in Latin America, 2022-2035
16.7.5.1. Clinical Trial Patient Recruitment Services Market in Latin America: Analysis by Trial Phase, 2022-2035
16.7.5.2. Clinical Trial Patient Recruitment Services Market in Latin America: Analysis by Therapeutic Area, 2022-2035
16.7.6. Clinical Trial Patient Recruitment Services Market in Middle East and North Africa, 2022-2035
16.7.6.1. Clinical Trial Patient Recruitment Services Market in Middle East and North Africa: Analysis by Trial Phase, 2022-2035
16.7.6.2. Clinical Trial Patient Recruitment Services Market in Middle East and North Africa: Analysis by Therapeutic Area, 2022-2035
16.7.7. Clinical Trial Patient Recruitment Services Market in Rest of the World, 2022-2035
16.7.7.1. Clinical Trial Patient Recruitment Services Market in Rest of the World: Analysis by Trial Phase, 2022-2035
16.7.7.2. Clinical Trial Patient Recruitment Services Market in Rest of the World: Analysis by Therapeutic Area, 2022-2035
17. IMPACT OF THE COVID-19 PANDEMIC ON PATIENT RECRUITMENT SERVICES MARKET
17.1. Chapter Overview
17.2. Impact of COVID-19 Pandemic on Clinical Trials
17.2.1. Impact on Opportunity Related to Patient Recruitment Services
17.2.2. Initiatives Undertaken by Key Patient Recruitment Companies
17.2.2.1. Trialspark
17.2.2.2. BBK Worldwide
17.2.2.3. Clariness
17.2.2.4. Clinical Site Services (CSSi)
17.2.2.5. IQVIA
17.3. Key Strategies Adopted to Mitigate the Challenges Associated with Patient Recruitment and Retention
18. CONCLUDING REMARKS
19. EXECUTIVE INSIGHTS
19.1. Chapter Overview
19.2. TrialWire
19.2.1. Company Snapshot
19.2.2. Interview Transcript: Susan Fitzpatrick-Napier, Founder and Director
19.3. Innovative Trials
19.3.1. Company Snapshot
19.3.2. Interview Transcript: Kate Shaw, Chief Executive Officer and Founder, and Marco Lassandro, Marketing and Communications Manager
19.4. Link2Trials
19.4.1. Company Snapshot
19.4.2. Interview Transcript: Simon Klaasen, Co-Founder and Managing Director
19.5. Clariness
19.5.1. Company Snapshot
19.5.2. Interview Transcript: Stefan Mayer-Eggersmann, Chief Commercial Officer
19.6. Continuum Clinical
19.6.1. Company Snapshot
19.6.2. Interview Transcript: Ken Shore, Chief Commercial Officer
19.7. nRollmed
19.7.1. Company Snapshot
19.7.2. Interview Transcript: Hagit Nof, Chief Operation Officer and Business Development Officer
19.8. Seeker Health
19.8.1. Company Snapshot
19.8.2. Interview Transcript: Paul Ivsin, Ex Managing Director
19.9. EVERSANA
19.9.1. Company Snapshot
19.9.2. Interview Transcript: Kasturi Lakhe, Inside Sales Specialist
20. APPENDIX 1: TABULATED DATA
21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Partnership and Collaborations
Figure 2.3 Executive Summary: Analysis of Demand for Clinical Trial Participants
Figure 2.4 Executive Summary: Market Sizing and Opportunity Analysis
Figure 3.1 Factors Contributing to Clinical Trial Cost
Figure 3.2 Patient Recruitment Process
Figure 3.3 Factors Influencing Participation in Clinical Trials
Figure 3.4 Reasons for Patient Dropouts from Clinical Studies
Figure 4.1 Patient Outreach: Advantages and Limitations of Traditional Methods
Figure 4.2 Patient Outreach: Advantages and Limitations of Social Media
Figure 5.1 Patient Recruitment Companies: Distribution by Year of Establishment
Figure 5.2 Patient Recruitment Companies: Distribution by Company Size
Figure 5.3 Patient Recruitment Companies: Distribution by Location of Headquarters (Region-wise)
Figure 5.4 Patient Recruitment Companies: Distribution by Location of Headquarters (Country-wise)
Figure 5.5 Patient Recruitment Companies: Distribution by Company Size and Location of Headquarters
Figure 5.6 Patient Recruitment Companies: Distribution by Patient Recruitment and Retention Services Offered
Figure 5.7 Patient Recruitment Companies: Distribution by Type of Patient Outreach Methods
Figure 5.8 Patient Recruitment Companies: Distribution by Number of Patient Outreach Methods Offered
Figure 5.9 Patient Recruitment Companies: Distribution by Patient Recruitment Associated Service(s) Offered
Figure 5.10 Patient Recruitment Companies: Distribution by Number of Patient Recruitment Associated Service(s) Offered
Figure 5.11 Patient Recruitment Companies: Distribution by Patient Retention Method(s) Used
Figure 5.12 Patient Recruitment Companies: Distribution by Number of Patient Retention Method(s) Used
Figure 5.13 Patient Recruitment Companies: Distribution by Geographical Reach
Figure 5.14 Patient Recruitment Companies: Distribution by Therapeutic Expertise
Figure 6.1 Company Competitiveness Analysis: Small Players
Figure 6.2 Company Competitiveness Analysis: Mid-sized Players
Figure 6.3 Company Competitiveness Analysis: Large and Very Large Players
Figure 10.1 Partnerships and Collaborations: Cumulative Year-wise Distribution, 2013-2022
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2013-2022
Figure 10.4 Partnerships and Collaborations: Distribution by Focus Area
Figure 10.5 Partnerships and Collaborations: Distribution by Year of Partnership and Focus Area
Figure 10.6 Partnerships and Collaborations: Distribution by Therapeutic Area
Figure 10.7 Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.8 Most Active Players: Distribution by Number of Partnerships
Figure 10.9 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
Figure 10.10 Partnerships and Collaborations: International and Local Deals
Figure 11.1 Patient Recruitment Services Market: Recent Trends
Figure 12.1 Patient Recruitment Services Market: Future Growth Opportunities
Figure 12.2 Global Clinical Trials Registered, 2000-2022
Figure 13.1 Patient Recruitment: Regulatory Pathway
Figure 13.2 Patient Recruitment: Regulatory Guidelines
Figure 14.1 Key Challenges in Patient Enrolment in Trials Focused on Personalized Medicines
Figure 14.2 Key Challenges in Patient Enrolment in Trials Focused on Rare Diseases
Figure 14.3 Specialized Patient Outreach Methods
Figure 15.1 Clinical Trial Analysis: Distribution by Trial Registration Year and Enrolled Patient Population
Figure 15.2 Clinical Trial Analysis: Distribution by Trial Phase
Figure 15.3 Global Demand for Clinical Trial Participants: Distribution by Enrolled Patient Population
Figure 15.4 Global Demand for Clinical Trial Participants: Distribution by Trial Phase
Figure 15.5 Global Demand for Clinical Trial Participants: Distribution by Therapeutic Area
Figure 15.6 Global Demand for Clinical Trial Participants: Distribution by Geography
Figure 16.1 Global Clinical Trial Patient Recruitment Services Market, 2022-2035 (USD Billion)
Figure 16.2 Clinical Trial Patient Recruitment Services Market: Distribution by Patient Recruitment Steps, 2022-2035 (USD Billion)
Figure 16.3 Clinical Trial Patient Recruitment Services Market: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.4 Clinical Trial Patient Recruitment Services Market: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.5 Clinical Trial Patient Recruitment Services Market: Distribution by Geography, 2022-2035 (USD Billion)
Figure 16.6 Clinical Trial Patient Recruitment Services Market, 2022 and 2035: Market Attractiveness Distribution by Country
Figure 16.7 Clinical Trial Patient Recruitment Services Market in North America, 2022-2035 (USD Billion)
Figure 16.8 Clinical Trial Patient Recruitment Services Market in the US: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.9 Clinical Trial Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.10 Clinical Trial Patient Recruitment Services Market in Canada: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.11 Clinical Trial Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.12 Clinical Trial Patient Recruitment Services Market in Europe, 2022-2035 (USD Billion)
Figure 16.13 Clinical Trial Patient Recruitment Services Market in Germany: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.14 Clinical Trial Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.15 Clinical Trial Patient Recruitment Services Market in France: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.16 Clinical Trial Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.17 Clinical Trial Patient Recruitment Services Market in the UK: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.18 Clinical Trial Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.19 Clinical Trial Patient Recruitment Services Market in Italy: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.20 Clinical Trial Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.21 Clinical Trial Patient Recruitment Services Market in Spain: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.22 Clinical Trial Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.23 Clinical Trial Patient Recruitment Services Market in Rest of Europe: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.24 Clinical Trial Patient Recruitment Services Market in Rest of Europe: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.25 Clinical Trial Patient Recruitment Services Market in Asia Pacific, 2022-2035 (USD Billion)
Figure 16.26 Clinical Trial Patient Recruitment Services Market in Japan: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.27 Clinical Trial Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.28 Clinical Trial Patient Recruitment Services Market in South Korea: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.29 Clinical Trial Patient Recruitment Services Market in South Korea, 2022-2035: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.30 Clinical Trial Patient Recruitment Services Market in Australia: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.31 Clinical Trial Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area (USD Billion)
Figure 16.32 Clinical Trial Patient Recruitment Services Market in China: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.33 Clinical Trial Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.34 Clinical Trial Patient Recruitment Services Market in India: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.35 Clinical Trial Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.36 Clinical Trial Patient Recruitment Services Market in Latin America, 2022-2035 (USD Billion)
Figure 16.37 Clinical Trial Patient Recruitment Services Market in Latin America: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.38 Clinical Trial Patient Recruitment Services Market in Latin America: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.39 Clinical Trial Patient Recruitment Services Market in Middle East and North Africa, 2022-2035 (USD Billion)
Figure 16.40 Clinical Trial Patient Recruitment Services Market in Middle East and North Africa: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.41 Clinical Trial Patient Recruitment Services Market in Middle East and North Africa: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.42 Clinical Trial Patient Recruitment Services Market in Rest of the World, 2022-2035 (USD Billion)
Figure 16.43 Clinical Trial Patient Recruitment Services Market in Rest of the World: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.44 Clinical Trial Patient Recruitment Services Market in Rest of the World, 2022-2035: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 18.1 Concluding Remarks: Overall Market Landscape
Figure 18.2 Concluding Remarks: Company Competitiveness Analysis
Figure 18.3 Concluding Remarks: Partnership and Collaborations
Figure 18.4 Concluding Remarks: Analysis of Demand for Clinical Trial Participants
Figure 18.5 Concluding Remarks: Market Sizing and Opportunity Analysis
Table 3.1 Key Characteristics of Clinical Trial Phases
Table 4.1 Traditional and Emerging Patient Outreach Methods
Table 5.1 List of Patient Recruitment and Retention Service Providers
Table 5.2 Clinical Trial Recruitment Companies: Information on Patient Outreach Methods
Table 5.3 Clinical Trial Recruitment Companies: Information on Type of Patient Recruitment Service(s) Offered
Table 5.4 Clinical Trial Recruitment Companies: Information on Patient Retention Method(s) Used and Geographical Reach
Table 5.5 Clinical Trial Recruitment Companies: Information on Therapeutic Expertise
Table 5.6 Clinical Trial Recruitment Companies: Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status
Table 7.1 Leading Clinical Trial Recruitment Companies in North America
Table 7.2 BBK Worldwide: Company Overview
Table 7.3 BBK Worldwide: Patient Recruitment and Retention Services Portfolio
Table 7.4 BBK Worldwide: Recent Developments and Future Outlook
Table 7.5 Continuum Clinical: Company Overview
Table 7.6 Continuum Clinical: Patient Recruitment and Retention Services Portfolio
Table 7.7 Continuum Clinical: Recent Developments and Future Outlook
Table 7.8 IQVIA: Company Overview
Table 7.9 IQVIA: Patient Recruitment and Retention Services Portfolio
Table 7.10 IQVIA: Recent Developments and Future Outlook
Table 7.11 United BioSource: Company Overview
Table 7.12 United BioSource: Patient Recruitment and Retention Services Portfolio
Table 7.13 United BioSource: Recent Developments and Future Outlook
Table 7.14 WCG ThreeWire: Company Overview
Table 7.15 WCG ThreeWire: Patient Recruitment and Retention Services Portfolio
Table 7.16 WCG ThreeWire: Recent Developments and Future Outlook
Table 8.1 Leading Clinical Trial Recruitment Companies in Europe
Table 8.2 Clariness: Company Overview
Table 8.3 Clariness: Patient Recruitment and Retention Services Portfolio
Table 8.4 Clariness: Recent Developments and Future Outlook
Table 8.5 Ignite Data: Company Overview
Table 8.6 Ignite Data: Patient Recruitment and Retention Services Portfolio
Table 8.7 Ignite Data: Recent Developments and Future Outlook
Table 8.8 Innovative Trials: Company Overview
Table 8.9 Innovative Trials: Patient Recruitment and Retention Services Portfolio
Table 8.10 Innovative Trials: Recent Developments and Future Outlook
Table 8.11 One Research: Company Overview
Table 8.12 One Research: Patient Recruitment and Retention Services Portfolio
Table 8.13 One Research: Recent Developments and Future Outlook
Table 8.14 Orphan Reach: Company Overview
Table 8.15 Orphan Reach: Patient Recruitment and Retention Services Portfolio
Table 8.16 Orphan Reach: Recent Developments and Future Outlook
Table 9.1 Leading Clinical Trial Recruitment Companies in Asia Pacific and Rest of the World
Table 9.2 3H Medi Solution: Company Overview
Table 9.3 3H Medi Solution: Patient Recruitment and Retention Services Portfolio
Table 9.4 3H Medi Solution: Recent Developments and Future Outlook
Table 9.5 Buzzreach: Company Overview
Table 9.6 Buzzreach: Patient Recruitment and Retention Services Portfolio
Table 9.7 Buzzreach: Recent Developments and Future Outlook
Table 9.8 Current Medical Information Center: Company Overview
Table 9.9 Current Medical Information Center: Patient Recruitment and Retention Services Portfolio
Table 9.10 Current Medical Information Center: Recent Developments and Future Outlook
Table 9.11 nRollmed: Company Overview
Table 9.12 nRollmed: Patient Recruitment and Retention Services PortfolioF
Table 9.13 Trialfacts: Company Overview
Table 9.14 Trialfacts: Patient Recruitment and Retention Services Portfolio
Table 9.15 Trialfacts: Recent Developments and Future Outlook
Table 10.1 Patient Recruitment Services: List of Partnerships and Collaborations, 2013-2022
Table 14.1 Patient Recruitment Companies: List of Trials Focused on Personalized Medicines and Rare Diseases
Table 19.1 TrialWire: Company Snapshot
Table 19.2 Innovative Trials: Company Snapshot
Table 19.3 Link2Trials: Company Snapshot
Table 19.4 Clariness: Company Snapshot
Table 19.5 Continuum Clinical: Company Snapshot
Table 19.6 nRollmed: Company Snapshot
Table 19.7 Seeker Health: Company Snapshot
Table 19.8 EVERSANA: Company Snapshot
Table 20.1 Factors Contributing to Clinical Trial Cost
Table 20.2 Clinical Trial Recruitment Companies: Distribution by Year of Establishment
Table 20.3 Clinical Trial Recruitment Companies: Distribution by Company Size
Table 20.4 Clinical Trial Recruitment Companies: Distribution by Location of Headquarters (Region-wise)
Table 20.5 Clinical Trial Recruitment Companies: Distribution by Location of Headquarters (Country-wise)
Table 20.6 Clinical Trial Recruitment Companies: Distribution by Company Size and Location of Headquarters
Table 20.7 Clinical Trial Recruitment Companies: Distribution by Patient Recruitment and Retention Services Offered
Table 20.8 Clinical Trial Recruitment Companies: Distribution by Type of Patient Outreach Methods
Table 20.9 Clinical Trial Recruitment Companies: Distribution by Number of Patient Outreach Methods Offered
Table 20.10 Clinical Trial Recruitment Companies: Distribution by Patient Recruitment Associated Service(s) Offered
Table 20.11 Clinical Trial Recruitment Companies: Distribution by Number of Patient Recruitment Associated Service(s) Offered
Table 20.12 Clinical Trial Recruitment Companies: Distribution by Patient Retention Method(s) Used
Table 20.13 Clinical Trial Recruitment Companies: Distribution by Number of Patient Retention Method(s) Used
Table 20.14 Clinical Trial Recruitment Companies: Distribution by Geographical Reach
Table 20.15 Clinical Trial Recruitment Companies: Distribution by Therapeutic Expertise
Table 20.16 Partnerships and Collaborations: Cumulative Year-wise Distribution, 2013-2022
Table 20.17 Partnerships and Collaborations: Distribution by Type of Partnership
Table 20.18 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2013-2022
Table 20.19 Partnerships and Collaborations: Distribution by Focus Area
Table 20.20 Partnerships and Collaborations: Distribution by Year of Partnership and Focus Area
Table 20.21 Partnerships and Collaborations: Distribution by Therapeutic Area
Table 20.22 Partnerships and Collaborations: Distribution by Type of Partner
Table 20.23 Most Active Players: Distribution by Number of Partnerships
Table 20.24 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Table 20.25 Partnerships and Collaborations: International and Local Distribution
Table 20.26 Global Clinical Trials Registered, 2000-2022
Table 20.27 Clinical Trial Analysis: Distribution by Trial Registration Year and Enrolled Patient Population
Table 20.28 Clinical Trial Analysis: Distribution by Trial Phase
Table 20.29 Global Demand for Clinical Trial Participants: Distribution by Enrolled Patient Population
Table 20.30 Global Demand for Clinical Trial Participants: Distribution by Trial Phase
Table 20.31 Global Demand for Clinical Trial Participants: Distribution by Therapeutic Area
Table 20.32 Global Demand for Clinical Trial Participants: Distribution by Geography
Table 20.33 Global Clinical Trial Patient Recruitment Services Market, 2022-2035 (USD Billion)
Table 20.34 Clinical Trial Patient Recruitment Services Market: Distribution by Patient Recruitment Steps, 2022-2035 (USD Billion)
Table 20.35 Clinical Trial Patient Recruitment Services Market: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.36 Clinical Trial Patient Recruitment Services Market: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.37 Clinical Trial Patient Recruitment Services Market: Distribution by Geography, 2022-2035 (USD Billion)
Table 20.38 Clinical Trial Patient Recruitment Services Market, 2022 and 2035: Market Attractiveness Distribution by Country
Table 20.39 Clinical Trial Patient Recruitment Services Market in North America, 2022-2035 (USD Billion)
Table 20.40 Clinical Trial Patient Recruitment Services Market in the US: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.41 Clinical Trial Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.42 Clinical Trial Patient Recruitment Services Market in Canada: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.43 Clinical Trial Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.44 Clinical Trial Patient Recruitment Services Market in Europe, 2022-2035 (USD Billion)
Table 20.45 Clinical Trial Patient Recruitment Services Market in Germany: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.46 Clinical Trial Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.47 Clinical Trial Patient Recruitment Services Market in France: Distribution by Trial Phase,2022-2035 (USD Billion)
Table 20.48 Clinical Trial Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.49 Clinical Trial Patient Recruitment Services Market in the UK: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.50 Clinical Trial Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.51 Clinical Trial Patient Recruitment Services Market in Italy: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.52 Clinical Trial Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.53 Clinical Trial Patient Recruitment Services Market in Spain: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.54 Clinical Trial Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.55 Clinical Trial Patient Recruitment Services Market in Rest of Europe: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.56 Clinical Trial Patient Recruitment Services Market in Rest of Europe: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.57 Clinical Trial Patient Recruitment Services Market in Asia Pacific, 2022-2035 (USD Billion)
Table 20.58 Clinical Trial Patient Recruitment Services Market in Japan: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.59 Clinical Trial Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.60 Clinical Trial Patient Recruitment Services Market in South Korea: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.61 Clinical Trial Patient Recruitment Services Market in South Korea, 2022-2035: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.62 Clinical Trial Patient Recruitment Services Market in Australia: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.63 Clinical Trial Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area (USD Billion)
Table 20.64 Clinical Trial Patient Recruitment Services Market in China: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.65 Clinical Trial Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.66 Clinical Trial Patient Recruitment Services Market in India: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.67 Clinical Trial Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.68 Clinical Trial Patient Recruitment Services Market in Latin America, 2022-2035 (USD Billion)
Table 20.69 Clinical Trial Patient Recruitment Services Market in Latin America: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.70 Clinical Trial Patient Recruitment Services Market in Latin America: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.71 Clinical Trial Patient Recruitment Services Market in Middle East and North Africa, 2022-2035 (USD Billion)
Table 20.72 Clinical Trial Patient Recruitment Services Market in Middle East and North Africa: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.73 Clinical Trial Patient Recruitment Services Market in Middle East and North Africa: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.74 Clinical Trial Patient Recruitment Services Market in Rest of the World, 2022-2035 (USD Billion)
Table 20.75 Clinical Trial Patient Recruitment Services Market in Rest of the World: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.76 Clinical Trial Patient Recruitment Services Market in Rest of the World, 2022-2035: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
The following companies and organizations have been mentioned in this report:
Source 1: https://www.clinicaltrialsarena.com/marketdata/featureclinical-trial-patient-recruitment/